Viral pseudotypes
Liebermann, H.
Archiv für Experimentelle Veterinarmedizin 39(1): 25-31
1985
ISSN/ISBN: 0003-9055 PMID: 3922327 Document Number: 261909
Document emailed within 1 workday
Related Documents
Van Tieghem, N.; Vercammen-Grandjean, A.; Beaumont, L.; Lejeune, F.J. 1978: Pseudotypes of VSV, after cultivation in a human melanoma (proceedings) Archives Internationales de Physiologie et de Biochimie 86(1): 213-214Závada, J.; Cerný, L.; Závadová, Z.; Bozonová, J.; Altstein, A.D. 1979: A rapid neutralization test for antibodies to bovine leukemia virus, with the use of rhabdovirus pseudotypes Journal of the National Cancer Institute 62(1): 95-101
Yerly, S.; Günthard, H.F.; Fagard, C.; Joos, Béda.; Perneger, T.V.; Hirschel, B.; Perrin, L. 2004: Proviral HIV-DNA predicts viral rebound and viral setpoint after structured treatment interruptions Aids 18(14): 1951-1953
González-Michaca, L.; Mercado, A.; Gamba, G. 2000: Viral C hepatitis in patients with end stage renal disease. II. Viral genotypes Revista de Investigacion Clinica; Organo del Hospital de Enfermedades de la Nutricion 52(5): 491-496
Tremolada, F.; Fattovich, G.; Panebianco, G.; Ongaro, G.; Realdi, G. 1980: Suppressor cell activity in viral and non-viral chronic active hepatitis Clinical and Experimental Immunology 40(1): 89-95
Barinskiĭ, I.F.; Nesterchuk, S.L. 1995: Killed specific viral vaccines for therapeutic use in chronic viral infections Voprosy Virusologii 40(1): 5-8
Odoyo-June, E.; Rogers, J.H.; Jaoko, W.; Bailey, R.C. 2013: Changes in plasma viral load and penile viral shedding after circumcision among HIV-positive men in Kisumu, Kenya Journal of Acquired Immune Deficiency Syndromes 64(5): 511-517
Kagan, G.I.; Postnikova, Z.A.; Rakovskaia, I.V.; Margunova, T.D.; Bykovskiĭ, A.F. 1976: Role of mixed mycoplasma-viral infection in viral leukemogenesis Vestnik Akademii Meditsinskikh Nauk SSSR 5: 86-93
Cathomas, G.; Bienz, K. 1989: Cytomegalovirus diagnosis in immunocompromised patients: detection of early viral protein and viral nucleic acids in shell vial culture Schweizerische Medizinische Wochenschrift 119(3): 75-80
Cheng, I.K.; Ho, S.K.; Fang, G.X.; Chan, D.T.; Lai, C.L. 1996: Usefulness of measurement of serum viral DNA using dot-blot hybridization and polymerase chain reaction in renal transplant patients with hepatitis B-positive viral infection Transplantation Proceedings 28(3): 1493-1494
Elsawa, S.F.; Bost, K.L. 2004: Murine gamma-herpesvirus-68-induced IL-12 contributes to the control of latent viral burden, but also contributes to viral-mediated leukocytosis Journal of Immunology 172(1): 516-524
Estill, J.; Aubrière, C.; Egger, M.; Johnson, L.; Wood, R.; Garone, D.; Gsponer, T.; Wandeler, G.; Boulle, A.; Davies, M.-A.; Hallett, T.B.; Keiser, O. 2012: Viral load monitoring of antiretroviral therapy, cohort viral load and HIV transmission in Southern Africa: a mathematical modelling analysis Aids 26(11): 1403-1413
Gromashevskiĭ, L.V.; Vasil'eva, V.L. 1972: Evolution of viruses and viral diseases. I. Evolution of viral parasitism in relation to the mechanism of transmission of the causative agents Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 49(12): 44-48
Pak, S.G.; Brodov, L.E.; Burnatseva, V.V.; Bogin, I.B. 1980: Clinical aspects of VZ viral hepatitis and the aggravating effect of herpes zoster on the course of infectious and serum viral hepatitis Klinicheskaia Meditsina 58(5): 47-49
Makarov, V.K.; Khomeriki, S.G. 2007: Serum lipids as biochemical manifestations of hepatic alcoholic, viral, and mixed viral-and-alcoholic lesion Klinicheskaia Laboratornaia Diagnostika 5: 17-19
Bocşan, I.S.; Gocan, G.; Ursu, L.; Brumboiu, M.I.; Soşa, I.; Simionca, L.; Sava, A.ţa.; Olaru, O.; Păştina, I. 2005: How protective is the immunization against viral hepatitis B prospectively? Seroprevalence study on viral hepatitis B infection Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 109(1): 124-130
Hobstová, J.; Vitous, A. 2011: Viral hepatitis at the beginning of the 21st century--value of liver biopsy in the context of development of new non-invasive diagnostic methods and in relation to the modern therapy of chronic viral hepatitis Ceskoslovenska Patologie 47(2): 44-49
Mekuria, L.A.; Prins, J.M.; Yalew, A.W.; Sprangers, M.A.G.; Nieuwkerk, P.T. 2016: Which adherence measure - self-report, clinician recorded or pharmacy refill - is best able to predict detectable viral load in a public ART programme without routine plasma viral load monitoring? Tropical Medicine and International Health: Tm and Ih 21(7): 856-869
Aleĭnik, M.D. 1970: Epidemiologic patterns in the spread of viral hepatitis. I. Dynamics of viral hepatitis morbidity Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 47(1): 63-66
Maki, K. 1979: Viral hepatitis and HB antigen. Viral hepatitis and occupation-related diseases Nursing Technique 25(3): 96-111